Linagliptin (BI-1356)
目录号: A11224
DPP-4 抑制剂
Linagliptin 是一种 DPP-4 抑制剂,它能抑制分解肠促胰岛素激素,如胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性胰岛素促进多肽(GIP)的酶。
Discription | Linagliptin is a DPP-4 inhibitor, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A11224 |
---|---|
分子式 | C25H28N8O2 |
分子量 | 472.5 |
CAS号 | 668270-12-0 |
SMILES | CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C |
其他名称 | BI-1356,Tradjenta,Trajenta |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 16 mg/mL (33.85 mM) | |
Water | Insoluble | ||
Ethanol | 1 mg/mL (2.11 mM) | ||
In vivo | 0.5% hydroxyethyl cellulose | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.16 mL | 105.82 mL | 211.64 mL |
0.5 mM | 4.23 mL | 21.16 mL | 42.33 mL |
1 mM | 2.12 mL | 10.58 mL | 21.16 mL |
5 mM | 0.42 mL | 2.12 mL | 4.23 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2